位置:首页 > 蛋白库 > NEMF_HUMAN
NEMF_HUMAN
ID   NEMF_HUMAN              Reviewed;        1076 AA.
AC   O60524; A0JLQ3; B3KSK1; B4DDL3; B4DHA9; B4E3F3; Q32Q66; Q8WW70; Q9NWG1;
DT   26-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   24-NOV-2009, sequence version 4.
DT   03-AUG-2022, entry version 166.
DE   RecName: Full=Ribosome quality control complex subunit NEMF {ECO:0000305|PubMed:25578875};
DE   AltName: Full=Antigen NY-CO-1;
DE   AltName: Full=Nuclear export mediator factor {ECO:0000312|HGNC:HGNC:10663};
DE   AltName: Full=Serologically defined colon cancer antigen 1;
GN   Name=NEMF {ECO:0000312|HGNC:HGNC:10663}; Synonyms=SDCCAG1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 1-1041 (ISOFORM 4), NUCLEOTIDE SEQUENCE [LARGE SCALE
RP   MRNA] OF 1-1049 (ISOFORM 5), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF
RP   1-518 (ISOFORM 1), AND VARIANT CYS-257.
RC   TISSUE=Astrocyte, Brain, Embryo, Thymus, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 418-1076 (ISOFORM 1).
RC   TISSUE=Small intestine;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H.,
RA   Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T.,
RA   Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B.,
RA   Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D.,
RA   Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R.,
RA   Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S.,
RA   Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C.,
RA   Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S.,
RA   Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C.,
RA   Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P.,
RA   Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J.,
RA   Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F.,
RA   Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F.,
RA   Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-438 AND 620-1076 (ISOFORM 1),
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-432 (ISOFORM 4), AND VARIANT
RP   CYS-257.
RC   TISSUE=Brain, Kidney, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 712-1076.
RC   TISSUE=Colon carcinoma;
RX   PubMed=9610721;
RX   DOI=10.1002/(sici)1097-0215(19980529)76:5<652::aid-ijc7>3.0.co;2-p;
RA   Scanlan M.J., Chen Y.-T., Williamson B., Gure A.O., Stockert E.,
RA   Gordan J.D., Tuereci O., Sahin U., Pfreundschuh M., Old L.J.;
RT   "Characterization of human colon cancer antigens recognized by autologous
RT   antibodies.";
RL   Int. J. Cancer 76:652-658(1998).
RN   [6]
RP   FUNCTION, INTERACTION WITH XPO1, AND TISSUE SPECIFICITY.
RX   PubMed=16103875; DOI=10.1038/sj.onc.1208962;
RA   Bi X., Jones T., Abbasi F., Lee H., Stultz B., Hursh D.A., Mortin M.A.;
RT   "Drosophila caliban, a nuclear export mediator, can function as a tumor
RT   suppressor in human lung cancer cells.";
RL   Oncogene 24:8229-8239(2005).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-417; SER-747; SER-748 AND
RP   SER-763, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-417, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-417 AND SER-831, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-417; SER-747 AND SER-748, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-7; SER-417 AND SER-831, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-417, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   INVOLVEMENT IN IDDSAPN.
RX   PubMed=27431290; DOI=10.1038/mp.2016.113;
RA   Anazi S., Maddirevula S., Faqeih E., Alsedairy H., Alzahrani F.,
RA   Shamseldin H.E., Patel N., Hashem M., Ibrahim N., Abdulwahab F., Ewida N.,
RA   Alsaif H.S., Al Sharif H., Alamoudi W., Kentab A., Bashiri F.A.,
RA   Alnaser M., AlWadei A.H., Alfadhel M., Eyaid W., Hashem A., Al Asmari A.,
RA   Saleh M.M., AlSaman A., Alhasan K.A., Alsughayir M., Al Shammari M.,
RA   Mahmoud A., Al-Hassnan Z.N., Al-Husain M., Osama Khalil R.,
RA   Abd El Meguid N., Masri A., Ali R., Ben-Omran T., El Fishway P.,
RA   Hashish A., Ercan Sencicek A., State M., Alazami A.M., Salih M.A.,
RA   Altassan N., Arold S.T., Abouelhoda M., Wakil S.M., Monies D., Shaheen R.,
RA   Alkuraya F.S.;
RT   "Clinical genomics expands the morbid genome of intellectual disability and
RT   offers a high diagnostic yield.";
RL   Mol. Psychiatry 22:615-624(2017).
RN   [16]
RP   INVOLVEMENT IN IDDSAPN, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=33048237; DOI=10.1007/s00439-020-02226-3;
RA   Ahmed A., Wang M., Bergant G., Maroofian R., Zhao R., Alfadhel M.,
RA   Nashabat M., AlRifai M.T., Eyaid W., Alswaid A., Beetz C., Qin Y., Zhu T.,
RA   Tian Q., Xia L., Wu H., Shen L., Dong S., Yang X., Liu C., Ma L., Zhang Q.,
RA   Khan R., Shah A.A., Guo J., Tang B., Leonardis L., Writzl K., Peterlin B.,
RA   Guo H., Malik S., Xia K., Hu Z.;
RT   "Biallelic loss-of-function variants in NEMF cause central nervous system
RT   impairment and axonal polyneuropathy.";
RL   Hum. Genet. 140:579-592(2021).
RN   [17] {ECO:0007744|PDB:3J92}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.60 ANGSTROMS) OF 1-501 AS PART OF THE
RP   RIBOSOME QUALITY CONTROL COMPLEX, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=25578875; DOI=10.1016/j.molcel.2014.12.015;
RA   Shao S., Brown A., Santhanam B., Hegde R.S.;
RT   "Structure and assembly pathway of the ribosome quality control complex.";
RL   Mol. Cell 57:433-444(2015).
RN   [18]
RP   VARIANTS IDDSAPN THR-553; 671-ARG--LYS-1076 DEL; 672-LYS--LYS-1076 DEL AND
RP   870-ARG--LYS-1076 DEL.
RX   PubMed=32934225; DOI=10.1038/s41467-020-18327-6;
RA   Martin P.B., Kigoshi-Tansho Y., Sher R.B., Ravenscroft G., Stauffer J.E.,
RA   Kumar R., Yonashiro R., Mueller T., Griffith C., Allen W., Pehlivan D.,
RA   Harel T., Zenker M., Howting D., Schanze D., Faqeih E.A.,
RA   Almontashiri N.A.M., Maroofian R., Houlden H., Mazaheri N., Galehdari H.,
RA   Douglas G., Posey J.E., Ryan M., Lupski J.R., Laing N.G., Joazeiro C.A.P.,
RA   Cox G.A.;
RT   "NEMF mutations that impair ribosome-associated quality control are
RT   associated with neuromuscular disease.";
RL   Nat. Commun. 11:4625-4625(2020).
CC   -!- FUNCTION: As part of the ribosome quality control complex (RQC), a
CC       ribosome-associated complex, mediates the extraction of incompletely
CC       synthesized nascent chains from stalled ribosomes as well as their
CC       ubiquitin-mediated proteasomal degradation. Thereby, frees ribosomes
CC       from the stalled translation complex and prevents the accumulation of
CC       nascent polypeptide chains that are potentially toxic for the cell. It
CC       is responsible both for selective recognition of stalled 60S subunits
CC       by recognizing an exposed, nascent chain-conjugated tRNA moiety and the
CC       recruitment of the E3 ubiquitin-protein ligase LTN1 to the ribosome
CC       quality control complex (PubMed:25578875). May indirectly play a role
CC       in nuclear export (PubMed:16103875). {ECO:0000269|PubMed:16103875,
CC       ECO:0000269|PubMed:25578875}.
CC   -!- SUBUNIT: Component of the ribosome quality control complex (RQC),
CC       composed of at least the E3 ubiquitin ligase LTN1 and NEMF associated
CC       with the 60S ribosomal subunit (PubMed:25578875). The complex probably
CC       also contains TCF25 as well as VCP/p97 and its ubiquitin-binding
CC       cofactors (By similarity). Interacts (via its N-terminus) with XPO1
CC       (PubMed:16103875). {ECO:0000250|UniProtKB:Q12532,
CC       ECO:0000269|PubMed:16103875, ECO:0000269|PubMed:25578875}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:25578875}.
CC       Nucleus {ECO:0000305|PubMed:16103875}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=O60524-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O60524-2; Sequence=VSP_008396, VSP_010462;
CC       Name=3;
CC         IsoId=O60524-3; Sequence=VSP_041066;
CC       Name=4;
CC         IsoId=O60524-4; Sequence=VSP_041064;
CC       Name=5;
CC         IsoId=O60524-5; Sequence=VSP_041065;
CC   -!- TISSUE SPECIFICITY: Expressed in brain, heart, liver, lung, spleen, and
CC       skeletal muscle. Also expressed at lower levels in stomach and testis.
CC       {ECO:0000269|PubMed:16103875, ECO:0000269|PubMed:33048237}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in the developing brain.
CC       {ECO:0000269|PubMed:33048237}.
CC   -!- DOMAIN: The N-terminal domain contains a nuclear export signal. The C-
CC       terminal domain may interact with cargo proteins (By similarity).
CC       {ECO:0000250}.
CC   -!- DISEASE: Intellectual developmental disorder with speech delay and
CC       axonal peripheral neuropathy (IDDSAPN) [MIM:619099]: An autosomal
CC       recessive disorder characterized by mild global developmental delay,
CC       mild to moderate intellectual disability, motor impairment, unsteady or
CC       ataxic gait, and severe speech delay apparent in the first years of
CC       life. Signs of a peripheral axonal neuropathy, including progressive
CC       distal muscle weakness and atrophy of the lower limbs, foot and hand
CC       deformities, and dysarthria, are observed in most patients. Some
CC       patients may have autistic features or attention deficit-hyperactivity
CC       disorder. {ECO:0000269|PubMed:27431290, ECO:0000269|PubMed:32934225,
CC       ECO:0000269|PubMed:33048237}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the NEMF family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC18036.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=AAH06001.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAH20794.2; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH56687.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAI07765.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAG52763.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAG58070.1; Type=Erroneous translation; Note=Wrong choice of frame.; Evidence={ECO:0000305};
CC       Sequence=BAG58070.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=BAG58070.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK000913; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK093783; BAG52763.1; ALT_INIT; mRNA.
DR   EMBL; AK293236; BAG56774.1; -; mRNA.
DR   EMBL; AK295010; BAG58070.1; ALT_SEQ; mRNA.
DR   EMBL; AK304695; BAG65465.1; -; mRNA.
DR   EMBL; BX640804; CAE45886.1; -; mRNA.
DR   EMBL; BX640807; CAE45889.1; -; mRNA.
DR   EMBL; BX648753; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AL591767; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL627171; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC006001; AAH06001.1; ALT_SEQ; mRNA.
DR   EMBL; BC020794; AAH20794.2; ALT_INIT; mRNA.
DR   EMBL; BC056687; AAH56687.1; ALT_SEQ; mRNA.
DR   EMBL; BC064364; AAH64364.1; -; mRNA.
DR   EMBL; BC107764; AAI07765.1; ALT_INIT; mRNA.
DR   EMBL; AF039687; AAC18036.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS9694.1; -. [O60524-1]
DR   RefSeq; NP_001288661.1; NM_001301732.2. [O60524-3]
DR   RefSeq; NP_004704.2; NM_004713.5. [O60524-1]
DR   PDB; 3J92; EM; 3.60 A; u/v=1-501.
DR   PDBsum; 3J92; -.
DR   AlphaFoldDB; O60524; -.
DR   SMR; O60524; -.
DR   IntAct; O60524; 24.
DR   MINT; O60524; -.
DR   STRING; 9606.ENSP00000298310; -.
DR   iPTMnet; O60524; -.
DR   PhosphoSitePlus; O60524; -.
DR   BioMuta; NEMF; -.
DR   EPD; O60524; -.
DR   jPOST; O60524; -.
DR   MassIVE; O60524; -.
DR   MaxQB; O60524; -.
DR   PaxDb; O60524; -.
DR   PeptideAtlas; O60524; -.
DR   PRIDE; O60524; -.
DR   ProteomicsDB; 49458; -. [O60524-1]
DR   ProteomicsDB; 49459; -. [O60524-2]
DR   ProteomicsDB; 49460; -. [O60524-3]
DR   ProteomicsDB; 49461; -. [O60524-4]
DR   ProteomicsDB; 49462; -. [O60524-5]
DR   Antibodypedia; 140; 219 antibodies from 29 providers.
DR   DNASU; 9147; -.
DR   Ensembl; ENST00000298310.10; ENSP00000298310.5; ENSG00000165525.18. [O60524-1]
DR   GeneID; 9147; -.
DR   KEGG; hsa:9147; -.
DR   MANE-Select; ENST00000298310.10; ENSP00000298310.5; NM_004713.6; NP_004704.3.
DR   UCSC; uc001wxc.4; human. [O60524-1]
DR   CTD; 9147; -.
DR   DisGeNET; 9147; -.
DR   GeneCards; NEMF; -.
DR   HGNC; HGNC:10663; NEMF.
DR   HPA; ENSG00000165525; Low tissue specificity.
DR   MalaCards; NEMF; -.
DR   MIM; 608378; gene.
DR   MIM; 619099; phenotype.
DR   neXtProt; NX_O60524; -.
DR   OpenTargets; ENSG00000165525; -.
DR   Orphanet; 88616; Autosomal recessive non-syndromic intellectual disability.
DR   PharmGKB; PA35593; -.
DR   VEuPathDB; HostDB:ENSG00000165525; -.
DR   eggNOG; KOG2030; Eukaryota.
DR   GeneTree; ENSGT00390000018516; -.
DR   HOGENOM; CLU_003612_1_0_1; -.
DR   InParanoid; O60524; -.
DR   OMA; MGAWWVN; -.
DR   OrthoDB; 131285at2759; -.
DR   PhylomeDB; O60524; -.
DR   TreeFam; TF300515; -.
DR   PathwayCommons; O60524; -.
DR   SignaLink; O60524; -.
DR   BioGRID-ORCS; 9147; 125 hits in 1083 CRISPR screens.
DR   ChiTaRS; NEMF; human.
DR   GenomeRNAi; 9147; -.
DR   Pharos; O60524; Tbio.
DR   PRO; PR:O60524; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; O60524; protein.
DR   Bgee; ENSG00000165525; Expressed in calcaneal tendon and 209 other tissues.
DR   ExpressionAtlas; O60524; baseline and differential.
DR   Genevisible; O60524; HS.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:1990112; C:RQC complex; IDA:UniProtKB.
DR   GO; GO:0043023; F:ribosomal large subunit binding; IBA:GO_Central.
DR   GO; GO:0000049; F:tRNA binding; IBA:GO_Central.
DR   GO; GO:0140708; P:CAT tailing; ISS:UniProtKB.
DR   GO; GO:0051168; P:nuclear export; IMP:UniProtKB.
DR   GO; GO:0065003; P:protein-containing complex assembly; IMP:UniProtKB.
DR   GO; GO:0072344; P:rescue of stalled ribosome; IBA:GO_Central.
DR   GO; GO:1990116; P:ribosome-associated ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   InterPro; IPR021846; NFACT-C.
DR   InterPro; IPR008532; NFACT_RNA-bd.
DR   Pfam; PF11923; NFACT-C; 1.
DR   Pfam; PF05670; NFACT-R_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Coiled coil; Cytoplasm;
KW   Disease variant; Intellectual disability; Neuropathy; Nucleus;
KW   Phosphoprotein; Reference proteome.
FT   CHAIN           1..1076
FT                   /note="Ribosome quality control complex subunit NEMF"
FT                   /id="PRO_0000097642"
FT   REGION          420..453
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          691..715
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          742..972
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          296..359
FT                   /evidence="ECO:0000255"
FT   COILED          483..514
FT                   /evidence="ECO:0000255"
FT   COILED          869..894
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        742..756
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        757..775
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        778..805
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        806..853
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        878..895
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        903..927
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        934..969
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         7
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         417
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         747
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         748
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         763
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         831
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..21
FT                   /note="MKSRFSTIDLRAVLAELNASL -> MPKTCQCYVGTKTTNPSAWPS (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_008396"
FT   VAR_SEQ         22..821
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_010462"
FT   VAR_SEQ         78..119
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_041064"
FT   VAR_SEQ         221..245
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_041065"
FT   VAR_SEQ         562..582
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_041066"
FT   VARIANT         257
FT                   /note="S -> C (in dbSNP:rs3100906)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334"
FT                   /id="VAR_034488"
FT   VARIANT         553
FT                   /note="I -> T (in IDDSAPN; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:32934225"
FT                   /id="VAR_085459"
FT   VARIANT         671..1076
FT                   /note="Missing (in IDDSAPN)"
FT                   /evidence="ECO:0000269|PubMed:32934225"
FT                   /id="VAR_085460"
FT   VARIANT         672..1076
FT                   /note="Missing (in IDDSAPN)"
FT                   /evidence="ECO:0000269|PubMed:32934225"
FT                   /id="VAR_085461"
FT   VARIANT         870..1076
FT                   /note="Missing (in IDDSAPN)"
FT                   /evidence="ECO:0000269|PubMed:32934225"
FT                   /id="VAR_085462"
FT   CONFLICT        53
FT                   /note="E -> K (in Ref. 1; BAG56774)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        438
FT                   /note="P -> S (in Ref. 4; AAH56687)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        495
FT                   /note="E -> G (in Ref. 1; BAG56774)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        560
FT                   /note="P -> PV (in Ref. 1; BAG58070)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        593
FT                   /note="A -> V (in Ref. 2; CAE45889)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        696
FT                   /note="E -> K (in Ref. 1; BAG65465)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        766
FT                   /note="E -> V (in Ref. 2; BX648753)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1076 AA;  122954 MW;  FCC5F95A0DB22F79 CRC64;
     MKSRFSTIDL RAVLAELNAS LLGMRVNNVY DVDNKTYLIR LQKPDFKATL LLESGIRIHT
     TEFEWPKNMM PSSFAMKCRK HLKSRRLVSA KQLGVDRIVD FQFGSDEAAY HLIIELYDRG
     NIVLTDYEYV ILNILRFRTD EADDVKFAVR ERYPLDHARA AEPLLTLERL TEIVASAPKG
     ELLKRVLNPL LPYGPALIEH CLLENGFSGN VKVDEKLETK DIEKVLVSLQ KAEDYMKTTS
     NFSGKGYIIQ KREIKPSLEA DKPVEDILTY EEFHPFLFSQ HSQCPYIEFE SFDKAVDEFY
     SKIEGQKIDL KALQQEKQAL KKLDNVRKDH ENRLEALQQA QEIDKLKGEL IEMNLQIVDR
     AIQVVRSALA NQIDWTEIGL IVKEAQAQGD PVASAIKELK LQTNHVTMLL RNPYLLSEEE
     DDDVDGDVNV EKNETEPPKG KKKKQKNKQL QKPQKNKPLL VDVDLSLSAY ANAKKYYDHK
     RYAAKKTQKT VEAAEKAFKS AEKKTKQTLK EVQTVTSIQK ARKVYWFEKF LWFISSENYL
     IIGGRDQQQN EIIVKRYLTP GDIYVHADLH GATSCVIKNP TGEPIPPRTL TEAGTMALCY
     SAAWDARVIT SAWWVYHHQV SKTAPTGEYL TTGSFMIRGK KNFLPPSYLM MGFSFLFKVD
     ESCVWRHQGE RKVRVQDEDM ETLASCTSEL ISEEMEQLDG GDTSSDEDKE EHETPVEVEL
     MTQVDQEDIT LQSGRDELNE ELIQEESSED EGEYEEVRKD QDSVGEMKDE GEETLNYPDT
     TIDLSHLQPQ RSIQKLASKE ESSNSSDSKS QSRRHLSAKE RREMKKKKLP SDSGDLEALE
     GKDKEKESTV HIETHQNTSK NVAAVQPMKR GQKSKMKKMK EKYKDQDEED RELIMKLLGS
     AGSNKEEKGK KGKKGKTKDE PVKKQPQKPR GGQRVSDNIK KETPFLEVIT HELQDFAVDD
     PHDDKEEQDL DQQGNEENLF DSLTGQPHPE DVLLFAIPIC APYTTMTNYK YKVKLTPGVQ
     KKGKAAKTAL NSFMHSKEAT AREKDLFRSV KDTDLSRNIP GKVKVSAPNL LNVKRK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024